These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 18031330)
1. Glanders: off to the races with Burkholderia mallei. Whitlock GC; Estes DM; Torres AG FEMS Microbiol Lett; 2007 Dec; 277(2):115-22. PubMed ID: 18031330 [TBL] [Abstract][Full Text] [Related]
2. A disruption of ctpA encoding carboxy-terminal protease attenuates Burkholderia mallei and induces partial protection in CD1 mice. Bandara AB; DeShazer D; Inzana TJ; Sriranganathan N; Schurig GG; Boyle SM Microb Pathog; 2008 Sep; 45(3):207-16. PubMed ID: 18614331 [TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962 [TBL] [Abstract][Full Text] [Related]
4. Detection of the host immune response to Burkholderia mallei heat-shock proteins GroEL and DnaK in a glanders patient and infected mice. Amemiya K; Meyers JL; Deshazer D; Riggins RN; Halasohoris S; England M; Ribot W; Norris SL; Waag DM Diagn Microbiol Infect Dis; 2007 Oct; 59(2):137-47. PubMed ID: 17908615 [TBL] [Abstract][Full Text] [Related]
5. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice. Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563 [TBL] [Abstract][Full Text] [Related]
6. [Glanders--a potential disease for biological warfare in humans and animals]. Lehavi O; Aizenstien O; Katz LH; Hourvitz A Harefuah; 2002 May; 141 Spec No():88-91, 119. PubMed ID: 12170562 [TBL] [Abstract][Full Text] [Related]
7. Detection of the reemerging agent Burkholderia mallei in a recent outbreak of glanders in the United Arab Emirates by a newly developed fliP-based polymerase chain reaction assay. Scholz HC; Joseph M; Tomaso H; Al Dahouk S; Witte A; Kinne J; Hagen RM; Wernery R; Wernery U; Neubauer H Diagn Microbiol Infect Dis; 2006 Apr; 54(4):241-7. PubMed ID: 16466896 [TBL] [Abstract][Full Text] [Related]
8. Characterization of cellular immune response and innate immune signaling in human and nonhuman primate primary mononuclear cells exposed to Burkholderia mallei. Alam S; Amemiya K; Bernhards RC; Ulrich RG; Waag DM; Saikh KU Microb Pathog; 2015 Jan; 78():20-8. PubMed ID: 25450887 [TBL] [Abstract][Full Text] [Related]
9. Construction of a reporter system to study Burkholderia mallei type III secretion and identification of the BopA effector protein function in intracellular survival. Whitlock GC; Estes DM; Young GM; Young B; Torres AG Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S127-33. PubMed ID: 19121674 [TBL] [Abstract][Full Text] [Related]
10. Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice. Ulrich RL; Amemiya K; Waag DM; Roy CJ; DeShazer D Vaccine; 2005 Mar; 23(16):1986-92. PubMed ID: 15734072 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis. Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423 [TBL] [Abstract][Full Text] [Related]
15. Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis. Tiyawisutsri R; Holden MT; Tumapa S; Rengpipat S; Clarke SR; Foster SJ; Nierman WC; Day NP; Peacock SJ BMC Microbiol; 2007 Mar; 7():19. PubMed ID: 17362501 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice. Bozue JA; Chaudhury S; Amemiya K; Chua J; Cote CK; Toothman RG; Dankmeyer JL; Klimko CP; Wilhelmsen CL; Raymond JW; Zavaljevski N; Reifman J; Wallqvist A Front Cell Infect Microbiol; 2016; 6():21. PubMed ID: 26955620 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614 [TBL] [Abstract][Full Text] [Related]
18. Type VI secretion is a major virulence determinant in Burkholderia mallei. Schell MA; Ulrich RL; Ribot WJ; Brueggemann EE; Hines HB; Chen D; Lipscomb L; Kim HS; Mrázek J; Nierman WC; Deshazer D Mol Microbiol; 2007 Jun; 64(6):1466-85. PubMed ID: 17555434 [TBL] [Abstract][Full Text] [Related]
19. Serodiagnosis of Burkholderia mallei infections in horses: state-of-the-art and perspectives. Neubauer H; Sprague LD; Zacharia R; Tomaso H; Al Dahouk S; Wernery R; Wernery U; Scholz HC J Vet Med B Infect Dis Vet Public Health; 2005 Jun; 52(5):201-5. PubMed ID: 16115091 [TBL] [Abstract][Full Text] [Related]
20. Pulsed-field gel electrophoresis as a discriminatory typing technique for the biothreat agent burkholderia mallei. Chantratita N; Vesaratchavest M; Wuthiekanun V; Tiyawisutsri R; Ulziitogtokh T; Akcay E; Day NP; Peacock SJ Am J Trop Med Hyg; 2006 Mar; 74(3):345-7. PubMed ID: 16525089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]